Evidence map›Paper›PMID 34471229›Full record

ArticleLeukemia2021

Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome.

Takashi Taga, Shiro Tanaka, Daisuke Hasegawa, Kiminori Terui, Tsutomu Toki, Shotaro Iwamoto, Hidefumi Hiramatsu, Takako Miyamura, Yoshiko Hashii, Hiroshi Moritake and 12 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Takashi Taga *Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan. ttaga@belle.shiga-med.ac.jp.ORCID http://orcid.org/0000-0003-0525-4766
Shiro Tanaka *Department of Clinical Biostatistics, Graduate School of Medicine Kyoto University, Kyoto, Japan.
Daisuke Hasegawa *Department of Pediatrics, St Luke's International Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0002-9446-9568
Kiminori TeruiDepartment of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Tsutomu TokiDepartment of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.ORCID http://orcid.org/0000-0002-0061-9781
Shotaro IwamotoDepartment of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.ORCID http://orcid.org/0000-0002-7710-2449
Hidefumi HiramatsuDepartment of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto, Japan.ORCID http://orcid.org/0000-0003-3136-5670
Takako MiyamuraDepartment of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan.ORCID http://orcid.org/0000-0002-3226-556X
Yoshiko HashiiDepartment of Cancer Immunotherapy, Osaka University Graduate School of Medicine, Suita, Japan.
Hiroshi MoritakeDivision of Pediatrics, Department of Reproductive and Developmental Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.ORCID http://orcid.org/0000-0001-5471-7646
Hideki NakayamaDepartment of Pediatrics, Kyushu Cancer Center, Fukuoka, Japan.ORCID http://orcid.org/0000-0002-1994-113X
Hiroyuki TakahashiDepartment of Pediatrics, Toho University, Tokyo, Japan.ORCID http://orcid.org/0000-0001-8763-0280
Akira ShimadaDepartment of Pediatrics, Okayama University Graduate School of Medicine, Okayama, Japan.
Tomohiko TakiLaboratory of Clinical Hematology, Department of Medical Technology, Kyorin University Faculty of Health Sciences, Mitaka, Japan.
Etsuro ItoDepartment of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.ORCID http://orcid.org/0000-0002-0168-2475
Asahito HamaDepartment of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.ORCID http://orcid.org/0000-0002-7582-0201
Masafumi ItoDepartment of Pathology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Katsuyoshi KohDepartment of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.ORCID http://orcid.org/0000-0002-0476-4978
Daiichiro HasegawaDepartment of Hematology/Oncology, Hyogo Children's Medical Center, Kobe, Japan.
Akiko M SaitoClinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
Souichi AdachiHuman Health Science, Kyoto University, Kyoto, Japan.
Daisuke TomizawaDivision of Leukemia and Lymphoma, Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.ORCID http://orcid.org/0000-0003-1520-7007

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34471229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.